+919405117673
Acabrunat Capsules 100 mg (30’s) | Trusted Pharmaceutical Export from India | Global Bulk Supply
Cordium Pharmaceuticals Pvt Ltd is a globally recognized pharmaceutical exporter from India, delivering high-quality Acabrunat Capsules 100 mg (30’s) with assured compliance, safety standards, and fast international shipping.

We specialize in bulk pharmaceutical supply and export-quality medicines to multiple countries including:

πŸ‡ΊπŸ‡Έ United States
πŸ‡¬πŸ‡§ United Kingdom
πŸ‡©πŸ‡ͺ Germany
πŸ‡³πŸ‡± Netherlands
πŸ‡ΏπŸ‡¦ South Africa
πŸ‡¦πŸ‡ͺ United Arab Emirates
πŸ‡§πŸ‡· Brazil

With a strong logistics network, we ensure quick dispatch, secure packaging, and timely global delivery for all pharmaceutical requirements.

πŸ’Š PRODUCT INFORMATION
Product Name: Acabrunat Capsules
Strength: 100 mg
Pack Size: 30 Capsules
Manufacturer/Exporter: Cordium Pharmaceuticals Pvt Ltd (India)
πŸ§ͺ USES / INDICATIONS

Acabrunat Capsules are generally used under medical supervision for:

Supportive therapeutic treatment as prescribed by healthcare professionals
Management of specific health conditions as per formulation guidelines
Pharmaceutical-grade clinical applications

⚠️ Use strictly under registered medical practitioner guidance.

πŸ“Œ DOSAGE INFORMATION
Recommended dosage: As prescribed by physician only
Do not self-medicate
Follow full prescribed course for best results
Take with or without food depending on medical advice
⚠️ SIDE EFFECTS

Some possible side effects may include:

Mild nausea or stomach discomfort
Headache or dizziness
Allergic reactions in sensitive individuals
Fatigue in rare cases

🚨 Discontinue use and consult a doctor if severe reactions occur.

🚚 GLOBAL EXPORT & FAST DELIVERY

We ensure fast and reliable pharmaceutical export services to:

North America
Europe
Middle East
Africa
South America

βœ” GMP-certified sourcing
βœ” Secure export packaging
βœ” On-time international shipping
βœ” Bulk order support

πŸ“ž CONTACT FOR BULK ORDERS

πŸ“± WhatsApp: +91-9405117673
πŸ“§ Email: info@cordiumpharma.com
Apr 18th, 2026 5:44 PM

Keywords